As of 2025-05-17, the EV/EBITDA ratio of Sumitomo Dainippon Pharma Co Ltd (4506.T) is -3.19. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 4506.T's latest enterprise value is 620,480.70 mil JPY. 4506.T's TTM EBITDA according to its financial statements is -194,628.00 mil JPY. Dividing these 2 quantities gives us the above 4506.T EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 4.3x - 6.7x | 5.5x |
| Forward P/E multiples | 6.4x - 8.0x | 7.7x |
| Fair Price | (3,856.87) - (3,984.05) | (3,954.70) |
| Upside | -563.0% - -578.3% | -574.8% |
| Date | EV/EBITDA |
| 2024-12-10 | -2.74 |
| 2024-12-09 | -2.66 |
| 2024-12-06 | -2.66 |
| 2024-12-05 | -2.63 |
| 2024-12-04 | -2.62 |
| 2024-12-03 | -2.63 |
| 2024-12-02 | -2.65 |
| 2024-11-29 | -2.64 |
| 2024-11-28 | -2.68 |
| 2024-11-27 | -2.72 |
| 2024-11-26 | -2.71 |
| 2024-11-25 | -2.74 |
| 2024-11-22 | -2.73 |
| 2024-11-21 | -2.73 |
| 2024-11-20 | -2.70 |
| 2024-11-19 | -2.72 |
| 2024-11-18 | -2.68 |
| 2024-11-15 | -2.71 |
| 2024-11-14 | -2.69 |
| 2024-11-13 | -2.78 |
| 2024-11-12 | -2.72 |
| 2024-11-11 | -2.72 |
| 2024-11-08 | -2.69 |
| 2024-11-07 | -2.69 |
| 2024-11-06 | -2.69 |
| 2024-11-05 | -2.68 |
| 2024-11-01 | -2.61 |
| 2024-10-31 | -2.56 |
| 2024-10-30 | -2.58 |
| 2024-10-29 | -2.75 |
| 2024-10-28 | -2.74 |
| 2024-10-25 | -2.70 |
| 2024-10-24 | -2.78 |
| 2024-10-23 | -2.75 |
| 2024-10-22 | -2.75 |
| 2024-10-21 | -2.76 |
| 2024-10-18 | -2.85 |
| 2024-10-17 | -2.83 |
| 2024-10-16 | -2.82 |
| 2024-10-15 | -2.83 |
| 2024-10-11 | -2.82 |
| 2024-10-10 | -2.83 |
| 2024-10-09 | -2.85 |
| 2024-10-08 | -2.85 |
| 2024-10-07 | -2.82 |
| 2024-10-04 | -2.81 |
| 2024-10-03 | -2.81 |
| 2024-10-02 | -2.70 |
| 2024-10-01 | -2.73 |
| 2024-09-30 | -2.70 |